Engagement for Impact:
Experience from a study conducted with the Pakistan National Tuberculosis Control Program
Early engagement with end-users of research is, increasingly, seen as essential if findings are to beapplied after a study concludes. This example from Pakistan gives insight into the why and how of such an approach.
A collaborative study – by a team from the London School of Hygiene & Tropical Medicine (LSHTM), the Pakistan National TB Control Programme and the Research Alliance for Advocacy and Development in Pakistan – involved stakeholders from the start of the research. The study assessed whether patients with pulmonary multi-drug resistant tuberculosis have better treatment outcomes if they are treated using quality-assured, internationally procured (GLC) drugs as compared to locally procured drugs. Early stakeholder engagement and collaboration helped to ensure buy-in and uptake, from policy level (by the National Tuberculosis Programme) to hospital level (staff, clinicians and data managers).
Dr Mishal Khan is a senior LSHTM research fellow trained in epidemiological and operational research. Her experience and interest lie in developing and testing low cost, locally appropriate interventions to improve the health of vulnerable groups. Mishal’s research areas include gender inequalities in health, health systems improvement and increasing tuberculosis (TB) case-detection. She received a Commonwealth Scholarship to complete her doctoral studies at the LSHTM and holds a Masters degree in Control of Infectious Diseases from the LSHTM and a Masters degree in Natural Sciences (Pathology) from the University of Cambridge.
Webinar Instructions
Please note that there are THREE STEPS involved in participation.
1. Register ahead of time - now, if you can! - here:
2. Log into Ready Talk before the presentation begins, so you can see the slides
3. Dial into Ready Talk on your telephone before the presentation begins, so you can hear the presenter speaking.
Times:
8:00 am Washington, DC
1:00pm London
2:00pm Geneva/Oslo/Johannesburg
3:00pm Mwanza/Kampala
5:30pm New Delhi
On the day:****You must call inANDjoin online to hear audio and view the presentation****
1) Dial In using your country's toll-free number (below) and access code 9272774
2) Log into Ready Talkhereas a participant using access code 9272774
Toll-free numbers:
Canada: 18667401260
Germany: 08006645316
India: 0008006501480
India - Reliance: 00080018774464138
Norway: 80056434
South Africa: 0800990940
Switzerland: 0800705351
United Kingdom: 08004960576
United States: 8667401260
Other toll free numbers can be found here
**NB If your country does not have a toll-free number, please email your contact number with country code to by Monday 21October to be dialled in 10-15 minutes prior to the start of the call.
STRIVE is a research consortium based at the London School of Hygiene and Tropical Medicine, with partners in India, Tanzania, South Africa and elsewhere, focusing on the structural forces - in particular stigma, gender-based violence, limited livelihood options and drinking norms - that combine in different ways to create vulnerability to HIV transmission and to undermine prevention.
Visitthe STRIVEwebsite and youtube channel
Follow STRIVE on Twitter @hivdrivers
To suggest other participants (giving their names, organisations, work focus and email address) OR to be removed from the invitation list, please email .
STRIVE is supported by UKaid from the Department for International Development. However, the views expressed do not necessarily reflect the department’s official policies.
***
Annie Holmes | Director of ResearchUptake
STRIVE Research Consortium: Tackling the Structural Drivers of HIV
London School of Hygiene& Tropical Medicine
15 - 17 Tavistock Place
WC1H 9SH
T: 44 (0)20 7927 2536
Follow STRIVE on Twitter @hivdrivers